Iridex and Topcon have entered into a strategic collaboration, according to a press release.
The agreement provides $19.5 million in cash to Iridex, the release said, which will provide funding for multiple years and will allow Iridex to pursue strategic growth initiatives. In return, Topcon purchased exclusive distribution rights for Iridex’s retina and glaucoma products in specific markets and acquired a common equity stake in Iridex of about 10.4%.
“Joining Topcon’s comprehensive distribution network throughout Asia Pacific and key EMEA regions will help Iridex to
Uncategorized